Microencapsulated phages show prolonged stability in gastrointestinal environments and high therapeutic efficiency to treat Escherichia coli O157:H7 infection.

MLA

Yin, Hanjie, et al. “Microencapsulated Phages Show Prolonged Stability in Gastrointestinal Environments and High Therapeutic Efficiency to Treat Escherichia Coli O157:H7 Infection.” Veterinary Research, vol. 52, no. 1, Sept. 2021, p. 118. EBSCOhost, https://doi.org/10.1186/s13567-021-00991-1.

APA

Yin, H., Li, J., Huang, H., Wang, Y., Qian, X., Ren, J., Xue, F., Dai, J., & Tang, F. (2021). Microencapsulated phages show prolonged stability in gastrointestinal environments and high therapeutic efficiency to treat Escherichia coli O157:H7 infection. Veterinary Research, 52(1), 118. https://doi.org/10.1186/s13567-021-00991-1

Chicago

Yin, Hanjie, Jing Li, Haosheng Huang, Yuxin Wang, Xinjie Qian, Jianluan Ren, Feng Xue, Jianjun Dai, and Fang Tang. 2021. “Microencapsulated Phages Show Prolonged Stability in Gastrointestinal Environments and High Therapeutic Efficiency to Treat Escherichia Coli O157:H7 Infection.” Veterinary Research 52 (1): 118. doi:10.1186/s13567-021-00991-1.